Effervescent NaDCC Tablet

Hazard statements (CLP)

H319, H335, H410

Code

Statements

H319

Causes serious eye irritation

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the mixture according to regulation (EC) No. 1272/2008 (CLP/GHS): Eye Irritant: Category 2 – causes serious eye irritation Target Organ Toxicity (single exposure): Category 3 – May cause respiratory tract irritation Hazardous to Aquatic Environment - Acute Hazard: Category 1 - Very toxic to aquatic life Hazardous to Aquatic Environment - Chronic Hazard: Category 1 - Very toxic to aquatic life with long lasting effects

Additional information

EUH031 – Contact with acids liberates toxic gases

2.2 Label elements

Labelling in accordance with regulation (EC) No. 1272/2008 (CLP/GHS):

Health hazards

Statement(s) H319 - Causes serious eye irritation H335 - May cause respiratory irritation

Environmental hazards

Statement(s) H410 - Very toxic to aquatic life with long lasting effects

Supplemental label elements

EUH031- Contact with acids liberates toxic gas

Prevention

P261 - Avoid breathing dust/fumes P273 - Avoid release to the environment P280 –Wear protective gloves/protective clothing/eye protection/face protection

Response

P305 + P351 + P338 - IF IN EYES - Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337 + P313 - If eye irritation persists: Get medical advice/attention P312 - Call a POISON CENTER or doctor if you feel unwell P391 - Collect spillage

Precautionary statements

Storage P403 + P233 - Store in a well-ventilated place. Keep container tightly closed - Disposal P501 - Dispose of contents and container in accordance with applicable local, regional, national, and/or international regulations

2.3 Other hazards

Short-Term Exposure (Acute) Inhalation: This material contained in this tablet in solid form is not expected to produce respiratory effects. Particles of respirable size are generally not encountered. The respirable fraction for the tablet active ingredient is typically less than 0.1% by weight for the granular and extra granular grades. If it is ground or otherwise in a powdered form, effects similar to a corrosive substance may occur. May cause severe irritation of the respiratory tract with coughing, choking, pain and possibly burns of the mucous membranes. If significant or prolonged exposure occurs, pulmonary oedema may develop, either immediately or more often within a period of 5-72 hours. The symptoms may include tightness in the chest, dyspnea, frothy sputum, cyanosis, and dizziness. Physical findings may include moist rales, low blood pressure and high pulse pressure. Severe cases may be fatal. Eyes: This material is irritating to the eye. Direct contact may cause severe irritation, pain and burns, possibly severe, and permanent damage including blindness. The degree of injury depends on the concentration and duration of contact. Skin: Direct contact with wet material or moist skin may cause severe irritation, pain, and possibly burns. Dry material is less irritating than wet material. This material is not a skin sensitiser based on studies with guinea pigs. Ingestion: Not a likely route of exposure. Harmful if swallowed. Ingestion may cause immediate pain and severe burns of the mucous membranes. There may be discoloration of the tissues. Swallowing and speech may be difficult at first and then almost impossible. The effects on the oesophagus and gastrointestinal tract may range from irritation to severe corrosion. Oedema of the epiglottis and shock may occur. Repeated Exposure (Chronic) Based on animal studies, exposure to concentrations of monosodium cyanurate at the solubility limit may cause cardiovascular, kidney and urinary bladder effects.

Medical Conditions Generally Aggravated by Exposure

eye disorders, respiratory disorders, skin disorders and allergies TARGET ORGANS: cardiovascular system, kidneys, bladder.

PBT Substances

The substances contained in this preparation are not identified as PBT substances